FI894459A0 - Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina - Google Patents

Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina

Info

Publication number
FI894459A0
FI894459A0 FI894459A FI894459A FI894459A0 FI 894459 A0 FI894459 A0 FI 894459A0 FI 894459 A FI894459 A FI 894459A FI 894459 A FI894459 A FI 894459A FI 894459 A0 FI894459 A0 FI 894459A0
Authority
FI
Finland
Prior art keywords
quinolyloxazol
inhibitors
novel
preparation
protein kinase
Prior art date
Application number
FI894459A
Other languages
English (en)
Swedish (sv)
Other versions
FI93112C (fi
FI93112B (fi
FI894459A (fi
Inventor
Winton Dennis Jones
Richard Cyrus Dage
George Philip Claxton
Hsien Chang Cheng
Phillip James Robinson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI894459A0 publication Critical patent/FI894459A0/fi
Publication of FI894459A publication Critical patent/FI894459A/fi
Application granted granted Critical
Publication of FI93112B publication Critical patent/FI93112B/fi
Publication of FI93112C publication Critical patent/FI93112C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
FI894459A 1988-10-24 1989-09-20 Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina FI93112C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26143588 1988-10-24
US07/261,435 US4886811A (en) 1988-10-24 1988-10-24 Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Publications (4)

Publication Number Publication Date
FI894459A0 true FI894459A0 (fi) 1989-09-20
FI894459A FI894459A (fi) 1990-04-25
FI93112B FI93112B (fi) 1994-11-15
FI93112C FI93112C (fi) 1995-02-27

Family

ID=22993289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894459A FI93112C (fi) 1988-10-24 1989-09-20 Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina

Country Status (21)

Country Link
US (1) US4886811A (fi)
EP (1) EP0365863B1 (fi)
JP (2) JP2879454B2 (fi)
KR (1) KR0162637B1 (fi)
CN (1) CN1025854C (fi)
AR (1) AR246733A1 (fi)
AT (1) ATE110074T1 (fi)
AU (1) AU613302B2 (fi)
CA (1) CA2000804C (fi)
DE (1) DE68917556T2 (fi)
DK (1) DK461389A (fi)
ES (1) ES2061863T3 (fi)
FI (1) FI93112C (fi)
HU (1) HUT58088A (fi)
IE (1) IE893011L (fi)
IL (1) IL91788A (fi)
NO (1) NO894210L (fi)
NZ (1) NZ230718A (fi)
PH (1) PH27450A (fi)
PT (1) PT91870B (fi)
ZA (1) ZA897259B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
US5190957A (en) * 1989-11-13 1993-03-02 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
PH27309A (en) * 1989-11-13 1993-05-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
ZA908936B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE406909T1 (de) * 1993-05-13 2008-09-15 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB9929216D0 (en) * 1999-12-11 2000-02-02 Univ Bristol Isoquinoline and Quinoline Containing substances
WO2006130090A1 (en) * 2005-06-03 2006-12-07 Pronas Pharma Ab Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025215A (en) * 1959-07-29 1962-03-13 Monsanto Chemicals Bis (8-quinolyl carbonate) derivatives
US3857877A (en) * 1973-01-12 1974-12-31 Karamchand Premchand Private 8-hydroxy quinoline derivatives
US4565820A (en) * 1980-07-28 1986-01-21 Pfizer Inc. Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles

Also Published As

Publication number Publication date
JPH02164878A (ja) 1990-06-25
JP2983970B2 (ja) 1999-11-29
ES2061863T3 (es) 1994-12-16
ATE110074T1 (de) 1994-09-15
JPH11152285A (ja) 1999-06-08
FI93112C (fi) 1995-02-27
DK461389D0 (da) 1989-09-19
DK461389A (da) 1990-04-25
HUT58088A (en) 1992-01-28
AU613302B2 (en) 1991-07-25
US4886811A (en) 1989-12-12
FI93112B (fi) 1994-11-15
HU895410D0 (en) 1990-01-28
DE68917556T2 (de) 1994-12-15
NZ230718A (en) 1990-11-27
CA2000804C (en) 1999-04-06
EP0365863A3 (en) 1990-11-07
JP2879454B2 (ja) 1999-04-05
KR0162637B1 (ko) 1998-12-01
CN1042145A (zh) 1990-05-16
ZA897259B (en) 1990-07-25
EP0365863B1 (en) 1994-08-17
NO894210D0 (no) 1989-10-23
IL91788A (en) 1994-04-12
PT91870B (pt) 1995-05-31
IL91788A0 (en) 1990-06-10
CA2000804A1 (en) 1990-04-24
AR246733A1 (es) 1994-09-30
IE893011L (en) 1990-04-24
KR900006307A (ko) 1990-05-07
NO894210L (no) 1990-04-25
AU4249389A (en) 1990-04-26
CN1025854C (zh) 1994-09-07
EP0365863A2 (en) 1990-05-02
DE68917556D1 (de) 1994-09-22
PH27450A (en) 1993-07-02
FI894459A (fi) 1990-04-25
PT91870A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI892248A0 (fi) Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi
PT86600A (pt) Process for the preparation of anticoagulant peptides
FI894459A (fi) Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina
FI98830B (fi) Menetelmä bifunktionaalisten proteiinien valmistamiseksi
FI883632A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten eetterien valmistamiseksi
FI892058A0 (fi) Fenolin valmistusmenetelmä
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI903704A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI93119B (fi) Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI891144A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
PT87503A (pt) Process for the preparation of new cathecolamine by products
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
NO890747D0 (no) Fremgangsmaate for fremstilling av halogen-substituerte ftalsyreanhydrider.
NO890748D0 (no) Fremgangsmaate for fremstilling av halogensubstituerte ftalsyreanhydrider.
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI93442B (fi) Menetelmä uusien kysteiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.